Musoke P - Search Results

1

Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.

Mandalakas AM, Guay L, Musoke P, Carroll-Pankhurst C, Olness KN. Mandalakas AM, et al. Among authors: musoke p. Pediatrics. 1999 Feb;103(2):E21. doi: 10.1542/peds.103.2.e21. Pediatrics. 1999. PMID: 9925867

2

Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.

Musoke PM, Young AM, Owor MA, Lubega IR, Brown ER, Mmiro FA, Mofenson LM, Jackson JB, Fowler MG, Guay LA. Musoke PM, et al. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):171-8. doi: 10.1097/QAI.0b013e318183a92a. J Acquir Immune Defic Syndr. 2008. PMID: 18769352 Free PMC article.

3

Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. Among authors: musoke p. J Infect Dis. 2001 Oct 1;184(7):914-7. doi: 10.1086/323153. Epub 2001 Aug 13. J Infect Dis. 2001. PMID: 11509999 Clinical Trial.

4

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB. Musoke P, et al. AIDS. 1999 Mar 11;13(4):479-86. doi: 10.1097/00002030-199903110-00006. AIDS. 1999. PMID: 10197376 Clinical Trial.

5

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH. Jackson JB, et al. Among authors: musoke p. AIDS. 2000 Jul 28;14(11):F111-5. doi: 10.1097/00002030-200007280-00001. AIDS. 2000. PMID: 10983633

6

Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.

Lubega IR, Fowler MG, Musoke PM, Elbireer A, Bagenda D, Kafulafula G, Ko J, Mipando L, Mubiru M, Kumwenda N, Taha T, Jackson JB, Guay L. Lubega IR, et al. J Acquir Immune Defic Syndr. 2010 Sep;55(1):58-64. doi: 10.1097/QAI.0b013e3181db059d. J Acquir Immune Defic Syndr. 2010. PMID: 20588184 Free PMC article.

7

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Guay LA, et al. Among authors: musoke p. Lancet. 1999 Sep 4;354(9181):795-802. doi: 10.1016/S0140-6736(99)80008-7. Lancet. 1999. PMID: 10485720 Free article. Clinical Trial.

8

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB. Eshleman SH, et al. Among authors: musoke p. AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006. AIDS. 2001. PMID: 11600822 Clinical Trial.

9

Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.

Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. Among authors: musoke p. AIDS Res Hum Retroviruses. 2004 Jun;20(6):595-9. doi: 10.1089/0889222041217518. AIDS Res Hum Retroviruses. 2004. PMID: 15242535 Clinical Trial.

10

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Marseille E, et al. Among authors: musoke p. Lancet. 1999 Sep 4;354(9181):803-9. doi: 10.1016/S0140-6736(99)80009-9. Lancet. 1999. PMID: 10485721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page